World Congress of Asthma 2018 - Scientific Program Committee's Message

Significant achievements have been accomplished in the last few years to better understanding what asthma is, how it should be assessed in regards to control and severity and what its optimal therapy is. Unfortunately, these improvements in our understanding of the disease have not always translated into better asthma management.

The 2018 World Congress on Asthma in Tokyo will review the key findings from recent research on both adult and pediatric Asthma and how knowledge translation methods have evolved to better integrate research findings into care.

The origins and determinants of Asthma, triggers and inducers, the new insight gained on the role of allergy, environmental and biodiversity changes, workplace hazards, respiratory infections and various aspects of assessment of the disease are among the topics that will be addressed by world experts. The role of phenotyping/endotyping Asthma, particularly when severe, and new therapeutic current and future advances will be covered.

A significant part of the meeting will be devoted to practical workshops on asthma testing and treatment delivery, as well as the integration of practice tools into day-to-day care. Sessions will discuss how to optimize the multidisciplinary approach to asthma management.

We and the members of the scientific advisory board are confident that the impressive program of WCA-2018 will be of interest to all those involved in research and care of asthma.

G. Walter Canonica       Lawrence DuBuske       Louis-Philippe Boulet       Fulvio Braido

http://wca-2018.com/

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma RT @Aller_MD: My Tweeted Times https://t.co/36WLWcQjoy - top stories by @sbernsteinmd
2hreplyretweetfavorite
Interasma RT @EAACI_HQ: Access the new, free and interactive map of #pollen and fungal spore monitoring stations around the world in a review publish…
2hreplyretweetfavorite
Interasma RT @worldallergy: Top story: FDA approves first generic version of EpiPen https://t.co/txYlepPuOE, see more https://t.co/yY235TM04T
2hreplyretweetfavorite
Interasma RT @worldallergy: Top story: The impact of allergen exposure and specific immunotherapy on circulating blood cells in allergic rhinitis | W…
2hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma